Louisa Umunna, DNP, CRNP in Bowie, MD - General Practice

Louisa Umunna, DNP, CRNP is a General Practice physician based in Bowie, Maryland. Louisa Umunna is licensed to practice in Maryland (license number R219965) and her current practice location is 5711 Hillmeade Rd, Bowie, Maryland. She can be reached at her office (for appointments etc.) via phone at (727) 424-1534.

NPI number for Louisa Umunna is 1609436518 and her current mailing address is 5711 Hillmeade Rd, Bowie, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1609436518.

Contact Information

	Louisa Umunna, DNP, CRNP
	5711 Hillmeade Rd, Bowie, MD 20720-4665
	(727) 424-1534
	Not Available

Physician's Profile

Full Name	Louisa Umunna
Gender	Female
Speciality	General Practice
Location	5711 Hillmeade Rd, Bowie, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1609436518
Provider Enumeration Date: 06/13/2019
Last Update Date: 10/11/2022

Medical Identifiers

Medical identifiers for Louisa Umunna such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1609436518	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	R219965 (Maryland)	Secondary
208D00000X	General Practice	R219965 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Louisa Umunna is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Louisa Umunna, DNP, CRNP 5711 Hillmeade Rd, Bowie, MD 20720-4665 Ph: (727) 424-1534	Louisa Umunna, DNP, CRNP 5711 Hillmeade Rd, Bowie, MD 20720-4665 Ph: (727) 424-1534

News Archive

Tagging vaping-related influencer Instagram posts is effective to discourage young people

Social media influencers vaping glamorously into their social media feeds are often not doing so for free. And new research suggests that calling out their pay-to-play posts as advertisements in a plain, obvious way might have an impact on young people.

Elevated BACE1 activity in mild cognitive impairment could be early indicator of AD, says study

The critical enzyme beta-secretase1 (BACE1) is known to be elevated in brains with sporadic Alzheimer disease (AD). Scientists have now found increased levels of BACE1 in brains with mild cognitive impairment (MCI), suggesting that BACE1 activity is important for conversion of mild cognitive impairment to AD and may be an early indicator of AD.

Youth smoking down in Nevada

A annual study conducted by the US Centers for Disease Control and the Nevada Department of Education confirms that fewer Nevada high school students obtained cigarettes by purchasing them in stores in 2003.

Treatment with methylphenidate helps adults with ADHD sleep

Treatment with methylphenidate (MPH) appears to have beneficial effects on sleep parameters in adults with ADHD, including increased sleep efficiency and a feeling of improved restorative value of sleep, according to a study published in the March 1 issue of the journal SLEEP.

German life sciences entrepreneurs granted option to develop Aeterna Zentaris' oral allogenic tumor vaccine technology

Aeterna Zentaris Inc. today announced that it has granted to German life sciences entrepreneurs with a proven track-record of funding the development and commercialization of biotechnology, an option to license the Company's live recombinant oral allogenic tumor vaccine technology, including AEZS-120, the most advanced product candidate for prostate cancer which is ready to enter a Phase 1 clinical trial.

Louisa Umunna, DNP, CRNP - General Practice in Bowie, MD